NXN and hepatocellular carcinoma: Kaplan-Meier analyses revealed that lower NXN expression was associated with shorter overall survival (OS) in HCC patients, both in our cohort and the TCGA cohort (P < 0.001 and P = 0.036, respectively; Fig. 1F, G).